Markets rise on Beijing summit as Trump’s Texas endorsement sparks Senate risk
The Dow Jones Industrial Average climbed 0.8% following the start of the US-China summit, while Nvidia shares surged on chip sales approval. Concurrently, the Financial Times reports that President Trump’s endorsement of a divisive candidate in Texas could shift the balance of power in the Senate.

US stock markets advanced on Thursday as President Donald Trump and Chinese President Xi Jinping commenced a two-day summit in Beijing. The Dow Jones Industrial Average gained 0.8 per cent, the S&P 500 rose 0.3 per cent, and the Nasdaq Composite climbed 0.2 per cent. The diplomatic engagement, which includes a delegation of major technology executives, focuses on trade, artificial intelligence, and tensions regarding Iran.
Nvidia shares surged more than 2 per cent following confirmation that the United States had approved the sale of H200 chips to Chinese firms. This regulatory clearance provided a specific catalyst for the semiconductor giant, contributing to the broader positive sentiment among investors as the summit began.
In a separate development with potential political ramifications, President Trump has endorsed a candidate for a Senate race in Texas. The Financial Times describes the endorsed figure as divisive, suggesting that the president’s support may be a strategic error that could make the Senate more competitive for the opposition.
Analysts indicate that this endorsement may put the Senate in play, potentially altering the balance of power in the chamber. The characterisation of the candidate as divisive is an interpretation by the Financial Times, and the assessment that the Senate is in play remains a predictive evaluation of political risk rather than a confirmed outcome.
The political analysis regarding the Texas race is distinct from the diplomatic and market developments surrounding the US-China summit. While markets reacted positively to the commencement of trade talks and chip sales approvals, the long-term implications of the Senate endorsement remain speculative and undetermined.


